Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First Patient Dosed in Phase 3 Registration Asian Study of Trodelvy for Breast Cancer

americanpharmaceuticalreviewDecember 30, 2020

Tag: Trodelvy , Breast Cancer , Everest Medicines , Sacituzumab Govitecan

PharmaSources Customer Service